Cases & Deals

  • Home
  • Practices
  • Major international pharmaceutical company devises global patent strategy based on safe harbor regimes

Share

Major international pharmaceutical company devises global patent strategy based on safe harbor regimes

September 2018

Client(s) Pharmaceutical company

Jones Day advised a major international pharmaceutical company on how to structure complex patent strategy in the EU and globally based on multiple safe harbor regimes.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.